Healthcare Industry News: American Medical Systems
News Release - October 24, 2006
ProUroCare Medical Announces the Appointment of Rick Carlson as Chief Executive Officer
MINNEAPOLIS--(HSMN NewsFeed)--ProUroCare Medical Inc. (OTCBB:PRRC ) and its Board of Directors are pleased to announce the appointment of Richard (Rick) C. Carlson as its Chief Executive Officer, effective November 1, 2006. Mr. Carlson succeeds Maurice Taylor, who announced his plan to retire as CEO but who will continue to serve as the Company's Chairman of the Board.Mr. Carlson brings a thorough knowledge of the product and the markets into which the product will be distributed to his new role as Chief Executive Officer. He has been instrumental in the development of the Company's ProUroScan(TM) system to date, and has authored the Company's plans for conducting clinical trials, making application for FDA approval, and commercializing the product.
Mr. Taylor, who has served as the Company's Chairman of the Board since its inception, added the role of Chief Executive Officer to his duties in March 2005. As part of the succession plan, Mr. Taylor will continue to act in an advisory role to Mr. Carlson through March 2007.
About ProUroCare
ProUroCare Medical Inc., based in Minneapolis, is developing innovative diagnostic and treatment approaches for male prostate disease and other genito-urinary related conditions. The company is primarily focused on tactile sensor technology and the ProUroScan(TM) system that is capable of identifying tissue abnormalities and mapping the prostate to assist the physician's diagnostic process. In addition, ProUroCare is developing the ProUroVision(TM) proprietary vision technology for thermal therapy systems to aid in the treatment of prostate-related diseases.
Source: ProUroCare Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
